Resmed (RMD) reported $5.1B in revenue for fiscal 2025, +9.8% year on year. That ranks #794 by revenue among 2853 SEC filers and #69 in Healthcare. Net income was $1.4B, a net margin of 27.2%. Revenue has grown 10.7% a year on average since 2012 ($1.4B then). The fiscal 2025 balance sheet shows $8.5B in total assets, $1.4B in cash and $404M in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $5.1B | +9.8% | FY20252025-06-30 |
| Gross profitGrossProfit | $3.1B | +15.1% | FY20252025-06-30 |
| Operating incomeOperatingIncomeLoss | $1.7B | +27.7% | FY20252025-06-30 |
| Net incomeNetIncomeLoss | $1.4B | +37.2% | FY20252025-06-30 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $1.8B | +25.0% | FY20252025-06-30 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $89.9M | −9.6% | FY20252025-06-30 |
| Total assetsAssets | $8.5B | +19.1% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $6.3B | +20.3% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $1.4B | +171.5% | FY20252025-12-31 |
| Long-term debtLongTermDebt | $404M | −39.1% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $1.4B | $399M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 17 of 161 companies compared | 27.2% | |
| Operating marginRank 13 of 160 companies compared | 32.7% | |
| R&D as share of revenueRank 61 of 102 companies compared | 6.4% | |
| Cash as share of revenueRank 28 of 160 companies compared | 27.5% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Resmed Inc
- Ticker
- RMD
- Exchange
- NYSE
- SIC classification
- Surgical & Medical Instruments & Apparatus (3841)
- Fiscal year end
- 06-30
- CIK
- 0000943819
Filings
- 10-KAug 13, 2026Open filing →
- 10-QMay 1, 2026Open filing →
- 10-QJan 30, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Option Care HealthOPCH | $5.6B | $208M |
| Beone MedicinesONC | $5.3B | $287M |
| Pacs GroupPACS | $5.3B | $192M |
| ResmedRMD | $5.1B | $1.4B |
| IncyteINCY | $5.1B | $1.3B |
| Bausch & LombBLCO | $5.1B | −$360M |
| Ensign GroupENSG | $5.1B | $344M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Resmed — Key figures |url=https://companiesranked.com/en/company/resmed |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Resmed — Key figures. CompaniesRanked. https://companiesranked.com/en/company/resmedBibTeX
@misc{companiesranked-en-company-resmed-2026,
author = {{CompaniesRanked}},
title = {{Resmed — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/resmed}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0000943819-26-000047 · August 13, 2026
{{cite web |title=Resmed — Key figures — 10-K (0000943819-26-000047) |url=https://www.sec.gov/Archives/edgar/data/943819/000094381926000047/rmd-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-13}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.